Laboratoire de Radiobiologie Cellulaire et Moléculaire, UMR CNRS 5822/IN2P3, IP2I, PRISME, Univ Lyon, Université Lyon 1, Faculté de Médecine Lyon-Sud, 69921 Oullins, France.
Département de Radiothérapie, Institut de Cancérologie de la Loire-Lucien Neuwirth, 42270 Saint Priest en Jarez, France.
Int J Mol Sci. 2020 Sep 29;21(19):7200. doi: 10.3390/ijms21197200.
We investigated the potential involvement of ceramide-enriched membrane domains in radiation-induced targeted and nontargeted effects using head and neck squamous cell carcinoma with opposite radiosensitivities. In radiosensitive SCC61 cells, the proportion of targeted effects was 34% and nontargeted effects killed 32% of cells. In contrast, only targeted effects (30%) are involved in the overall death of radioresistant SQ20B cells. We then demonstrated in SCC61 cells that nontargeted cell response was driven by the formation of the radiation-induced ceramide-enriched domain. By contrast, the existence of these platforms in SQ20B cells confers a permissive region for phosphatidylinositol-3-kinase (PI3K)/AKT activation. The disruption of lipid raft results in strong inhibition of PI3K/AKT signaling, leading to radiosensitization and apparition of nontargeted effects. These results suggest that ceramide-enriched platforms play a significant role in targeted and nontargeted effects during radiotherapy and that drugs modulating cholesterol levels may be a good alternative for improving radiotherapy effectiveness.
我们使用具有相反放射敏感性的头颈部鳞状细胞癌研究富含神经酰胺的膜域在放射诱导的靶向和非靶向效应中的潜在作用。在放射敏感的 SCC61 细胞中,靶向效应的比例为 34%,非靶向效应杀死了 32%的细胞。相比之下,只有靶向效应(30%)参与了放射抗性 SQ20B 细胞的整体死亡。然后,我们在 SCC61 细胞中证明,非靶向细胞反应是由辐射诱导的富含神经酰胺的域的形成驱动的。相比之下,这些平台在 SQ20B 细胞中的存在赋予了磷脂酰肌醇-3-激酶(PI3K)/ AKT 激活的许可区域。脂质筏的破坏导致 PI3K/AKT 信号的强烈抑制,从而导致放射增敏和非靶向效应的出现。这些结果表明,富含神经酰胺的平台在放射治疗过程中的靶向和非靶向效应中起着重要作用,调节胆固醇水平的药物可能是提高放射治疗效果的一个很好的选择。